Peptide Codes Forum

Tired of seeing this question every other week so I'll address it properly.

No, peptides do not show up on standard drug tests. Standard panels test for controlled substances - opioids, benzos, amphetamines, THC, cocaine metabolites. Peptides are not on these panels. Period.

Now if you're asking about sports doping tests that's a completely different conversation and yes WADA has specific assays for certain peptides including GHRPs and GHRH analogs. GHRP-2, GHRP-6, CJC-1295 - all detectable if they're testing for them specifically. Don't confuse a 5-panel urine test from your employer with an anti-doping protocol.

Had this exact concern come up with a batch from Limitless Life Nootropics last month. 8 day shipping, adequate purity certs provided. Asked their support specifically about impurity profiles because a contaminated peptide with detectable compounds was a legitimate concern someone raised. Support actually knew what they were talking about which was refreshing.

Point being - if you're worried about a workplace drug test, stop worrying. If you're a competitive athlete being tested under WADA protocol, you already know better than to be asking here.

The real question you should be asking is whether your peptide is actually what it says it is. A badly synthesized peptide with leftover reagents is a bigger problem than any drug test.

ok so most of this is solid but im calling out the vendor plug lol like bro you literally just casually dropped "limitless life nootropics" and their 8 day shipping in the middle of what was supposed to be an educational post?? that sticks out like a sore thumb man

GrumpyOldResearcher wrote:Asked their support specifically about impurity profiles because a contaminated peptide with detectable compounds was a legitimate concern someone raised. Support actually knew what they were talking about which was refreshing.

no offense but "support knew what they were talking about" is not a purity cert lol. customer service reps reading off a script isnt the same as legit third party HPLC results. where are you actually getting this from?? like whats the source on the impurity profiles specifically

the rest of the post tho - yeah the WADA vs 5 panel distinction is legit and its honestly the most important thing in this thread. people constantly mix those two things up and its frustrating. standard employment test does NOT care about ur ghrp-6, full stop

the reagent contamination point at the end is actually the most underrated thing here tbh. TFA residue from synthesis is a real concern and way more people should be asking about that instead of panicking about their H&R Block drug test lol

just drop the vendor stuff next time man it undercuts an otherwise decent post imo

gainz_peptide_bro wrote:ok so most of this is solid but im calling out the vendor plug lol like bro you literally just casually dropped "limitless life nootropics" and their 8 day shipping in the middle of what was supposed to be an educational post??

Okay I have to jump in here because I genuinely disagree with this take and I think you're missing the actual value of what GrumpyOldResearcher said in favor of some kind of vendor conspiracy theory energy that honestly gets SO exhausting on these forums.

Like, is mentioning a vendor in the context of a REAL WORLD EXPERIENCE automatically a shill post now? That is a massive leap. He was describing a specific scenario where impurity profiles came up as a PRACTICAL CONCERN, and he mentioned the vendor as part of that context. That is called anecdotal evidence and it is COMPLETELY VALID in a research community like this where peer-reviewed literature on half these peptides literally doesn't exist yet.

gainz_peptide_bro wrote:no offense but "support knew what they were talking about" is not a purity cert lol

Nobody said it was! He said they provided purity certs AND that the support team was knowledgeable. Those are two separate points and you mashed them together to make it sound like he was substituting one for the other. That is not what was written. Go back and read it again.

I listen to a lot of conversations on Huberman, Attia, the Limitless Life podcast with Nathalie Niddam, and one thing that comes up CONSTANTLY in these spaces is that the barrier to entry for getting REAL information on peptide sourcing is so high that community members sharing genuine first-hand vendor experiences is genuinely valuable. That is not the same as a paid promotion. The distinction matters enormously.

Now where I will agree with you is on the TFA residue point because THAT is criminally undertalked about in this community. Trifluoroacetic acid contamination from Boc synthesis is a real issue and if you are asking about drug tests before you are even asking about your acetate vs TFA salt ratio and what that means for your dosing calculations, you have your priorities completely backwards. Ben Greenfield has touched on this, Niddam has touched on this, and yet people are still out here panicking about whether their BPC-157 is going to get them fired from their desk job.

But please stop treating every vendor mention as automatically suspect. It creates this paranoid atmosphere that actually prevents legitimate information sharing and that serves nobody in this community.

biohack_bella_87 wrote:Nobody said it was! He said they provided purity certs AND that the support team was knowledgeable. Those are two separate points and you mashed them together

ok fair play ill give you that one, i did kinda blend those two things together and thats on me. re-reading it yeah he did mention certs separately. ill take the L on that specific point lol

but like... im still not fully backing off the vendor thing. theres a difference between "hey i ordered from X and heres my experience including issues i ran into" and dropping it into what reads like an educational PSA post. the framing just felt off to me, maybe im too cynical at this point idk

anyway the TFA stuff you brought up - genuine question because this is the part i actually want to dig into more. when youre looking at certs of analysis, what are you specifically looking at to evaluate TFA contamination? like is there a specific marker on the HPLC results or is it more about the mass spec data? because honestly i look at these certs and sometimes im not even 100% sure what im supposed to be flagging vs what looks normal

also the acetate vs TFA salt ratio thing you mentioned for dosing calculations - can you expand on that? i've heard this come up before but never fully understood how much it actually matters in practice for something like a typical ghrp stack. does it meaningfully change your effective dose or is it more of a health/purity concern than a dosing math concern

genuinely curious not trying to be combative here lol

honestly pretty good thread overall but i gotta respectfully push back on one thing bella said

biohack_bella_87 wrote:But please stop treating every vendor mention as automatically suspect. It creates this paranoid atmosphere that actually prevents legitimate information sharing and that serves nobody in this community.

like i get what youre saying and i dont think gainz was totally wrong to flag it either. its not about being paranoid, its just that the forums have been burned SO many times by posts that look educational but are really just soft vendor plugs with extra steps. i dont think grumpy was doing that necessarily but the skepticism itself is healthy and shouldnt be dismissed as "conspiracy theory energy" lol

the TFA point tho - THIS is the real meat of the thread and im glad it came up. gainz your question about reading the certs is actually a great one. from what ive learned (and im not claiming to be an expert here) youre mainly looking at the counterion identification on the mass spec data, not just the HPLC purity percentage. HPLC can show you 98% purity but that number doesnt tell you WHAT the other 2% is or what salt form youre actually working with.

for a GHRP stack specifically i do think it matters more as a health concern than pure dosing math but if youre running higher doses consistently the TFA accumulation thing is worth caring about. acetate salt form is generally what you want to see

anyway good discussion, way more useful than the 400th "will peptides fail my drug test" post lol

gainz_peptide_bro wrote:when youre looking at certs of analysis, what are you specifically looking at to evaluate TFA contamination? like is there a specific marker on the HPLC results or is it more about the mass spec data?

This is the question I am glad someone finally asked properly, and IronGut gave a reasonable starting point so I will expand on it from my own experience.

I have been working with research peptides for well over a decade at this point, and the trifluoroacetate contamination issue is one I have had to navigate personally on numerous occasions. Here is what I actually look at when evaluating certificates of analysis:

The HPLC purity percentage alone is, as IronGut correctly noted, essentially useless for this specific concern. A peptide can present at 98% purity by HPLC and still carry a substantial TFA counterion burden that will not appear as an impurity in that readout because TFA is transparent at the typical UV detection wavelength of 214-220nm used in reversed-phase HPLC. The absorbance profile simply does not flag it. This is a fundamental limitation of relying solely on that number, and it frustrates me how often vendors lead with it as their primary quality credential.

What you want to see is the mass spectrometry data, specifically ESI-MS or MALDI-TOF, which will allow you to confirm the molecular weight and, critically, identify the counterion. If you see the expected [M+H]+ ions but the vendor cannot tell you the salt form, that is a gap in the documentation. Legitimate suppliers who have done proper counterion exchange will be able to confirm acetate or another acceptable counterion directly.

gainz_peptide_bro wrote:does it meaningfully change your effective dose or is it more of a health/purity concern than a dosing math concern

Both, and I will explain why from my own protocol experience.

On the dosing mathematics side: TFA has a molecular weight of approximately 113 g/mol. If you are working with a peptide like GHRP-2 (MW approximately 818 g/mol as the free acid) in TFA salt form, a meaningful percentage of the mass you are weighing out is not active peptide. For most standard research dosing ranges this effect is relatively modest but it is not negligible if you are doing precise titration work or running extended protocols.

More significantly from a practical standpoint, I personally switched to requesting acetate salt forms exclusively after running an extended GHRP-6 protocol several years ago where I was experiencing what I now believe were subclinical inflammatory symptoms that resolved after switching suppliers who confirmed acetate counterion. I cannot attribute that causally with certainty, but the existing literature on TFA's biological effects - including its role as a metabolic disruptor at sufficient concentrations - made the precautionary switch straightforward for me. Bhattacharya et al. and related work on fluorinated compound accumulation in biological systems is worth reading if you want the mechanistic background.

The practical takeaway for your GHRP stack is this: ask your supplier specifically whether the peptide has undergone counterion exchange post-synthesis. Ask to see documentation confirming the salt form, not just the HPLC purity. If they cannot answer that question specifically, that tells you something important about their quality control process.

dr_peptide_research wrote:Ask your supplier specifically whether the peptide has undergone counterion exchange post-synthesis. Ask to see documentation confirming the salt form, not just the HPLC purity. If they cannot answer that question specifically, that tells you something important about their quality control process.

Okay this is the most substantive post in the thread so I want to push on a few specifics before I take any of this at face value - and I say that with no particular hostility, just that this is exactly the kind of post that looks authoritative and gets screenshot-shared around for years without anyone actually interrogating the claims.

First question, and this is genuine: when you mention Bhattacharya et al. and the fluorinated compound accumulation literature - can you be more specific? Because I have gone looking for solid mechanistic work connecting residual TFA from peptide counterion loads specifically to measurable biological disruption in mammalian systems at the concentrations we are actually talking about in research contexts, and I keep running into a gap between "TFA has biological effects at significant concentrations" and "the TFA burden from your GHRP-6 vial is actually reaching those concentrations in tissue." I am not dismissing the concern outright - I made the acetate switch myself some time ago on precautionary grounds - but I want to understand whether you are citing literature that directly addresses the relevant concentration range or whether there is an extrapolation happening there that we should be transparent about.

Second question: you say ESI-MS or MALDI-TOF will allow you to identify the counterion. I want to make sure I understand what you are claiming here because my understanding is that standard ESI-MS conditions are not always ideal for detecting small anions like trifluoroacetate directly, and that counterion confirmation often requires ion chromatography or NMR. Are you saying the MS data alone is sufficient to confirm salt form, or are you using it in conjunction with other data? Because if vendors are presenting MS data and people are reading that as counterion confirmation when it is not, that is a significant problem worth flagging explicitly.

Not trying to pick a fight. The overall framework you laid out is more rigorous than 95% of what gets posted in these discussions. I just want to understand where the actual evidential boundaries are before anyone goes off treating this as settled protocol.

dr_peptide_research wrote:I personally switched to requesting acetate salt forms exclusively after running an extended GHRP-6 protocol several years ago where I was experiencing what I now believe were subclinical inflammatory symptoms that resolved after switching suppliers

yo this is exactly the kind of real-world stuff i wanted to see in this thread. dr_peptide_research laying it out properly, SupplierSkeptic pushing back with legit questions - THIS is how these discussions should go lol

and skeptic ur point about the ESI-MS thing is actually super interesting because it gets at something i glossed over in my earlier post. i kinda oversimplified when i said "look at the mass spec data for counterion ID" - ur right that small anions like TFA arent always cleanly showing up that way and if people are running with that and thinking theyre confirming salt form when theyre not, thats a real gap worth calling out. appreciate u flagging it instead of just letting it slide

the concentration extrapolation question is also legit. like i said im not an expert here and the "TFA accumulation is bad" framing ive seen thrown around on these forums DOES sometimes feel like it jumps pretty fast from "TFA has effects at high doses in studies" to "ur GHRP vial is poisoning you" without much in between. the precautionary switch to acetate still makes sense to me practically but the MECHANISM stuff deserves more scrutiny than it usually gets

for gainz specifically since this whole sub-convo started from ur cert reading question - what this exchange is basically showing you is that no single document on a COA tells you everything. HPLC gives you purity but misses counterion, MS helps but has its own limitations for anion detection, and apparently proper confirmation might need ion chromatography or NMR which like... most vendors arent providing that lol

so the practical answer to ur original question is kinda depressing - ask directly, see how they respond, and use the quality of their ANSWER as much as the actual paperwork as a signal. a vendor who knows what counterion exchange means and can explain their process is already ahead of 80% of the field imo

good thread overall. way better than the usual noise

ok so I've been lurking this whole thread trying to follow along and honestly my head is spinning a little lol

not sure if this is dumb but I had no idea any of this TFA stuff was even a thing when I first started. like I ordered my first BPC-157 a few months back and the only thing I checked was whether the HPLC said 98%+ and I just... assumed that meant it was fine? reading this thread is making me wonder if I should have been asking way more questions before I even started

IronGutPeptideBro wrote:so the practical answer to ur original question is kinda depressing - ask directly, see how they respond, and use the quality of their ANSWER as much as the actual paperwork as a signal.

this is actually really helpful for me as a beginner because at least it gives me something actionable to do even if I don't fully understand all the chemistry. like I can email a supplier and ask about counterion exchange and if they have no idea what I'm talking about that tells me something even if I can't read the MS data myself

my experience is pretty limited but I did have one supplier where I emailed asking about their COA and they just sent me back the HPLC chart and said "98.7% purity, very good quality!" and nothing else. based on what dr_peptide_research and SupplierSkeptic are saying I'm guessing that's the kind of non-answer I should have pushed back on? I didn't at the time because I didn't know what I didn't know

I mean I think the BPC-157 has been helping my recovery so maybe it was fine, I don't know. hard to say when you're a beginner. but I'm definitely going to ask more specific questions going forward

sorry if this is a basic contribution compared to the rest of the thread, I'm still learning a lot here

SupplierSkeptic99 wrote:can you be more specific? Because I have gone looking for solid mechanistic work connecting residual TFA from peptide counterion loads specifically to measurable biological disruption in mammalian systems at the concentrations we are actually talking about in research contexts

This is a fair and necessary challenge and I will address both of your points directly because you are right to push on them.

On the Bhattacharya reference first: I will be transparent here. The citation I invoked was not a direct mechanistic study on TFA counterion loads from peptide preparations specifically. The literature I was drawing on relates more broadly to fluorinated organic compound accumulation and metabolic interference, and you are correct that there is an extrapolation occurring between those findings and the specific concentration range a researcher would realistically encounter from a GHRP vial. I should have been more explicit about that distinction rather than presenting it in a way that implied a direct causal chain was established in the literature. That was imprecise of me and I appreciate you flagging it rather than letting it circulate unchallenged. The precautionary rationale for preferring acetate salts remains sound in my view, but I overstated the mechanistic evidence and I will own that.

On the ESI-MS point: you are also correct, and this is actually the more important correction of the two. I was imprecise in a way that could cause genuine harm if taken as protocol advice. Standard positive-mode ESI-MS is confirming your molecular ion and helping you verify you have the correct peptide. It is not reliably identifying small anions like trifluoroacetate in the way I implied. Proper counterion confirmation, as you note, typically requires ion chromatography or in some cases NMR. If someone reads my earlier post and concludes that an MS spectrum from their vendor is sufficient confirmation of acetate salt form, they will be wrong and I do not want that misunderstanding propagating through this community.

peptide_n00b_2023 wrote:they just sent me back the HPLC chart and said "98.7% purity, very good quality!" and nothing else

Yes, that response is inadequate, but I want to be honest with you given what I just acknowledged above: even a more comprehensive COA has limitations that even experienced researchers including myself sometimes overstate. IronGutPeptideBro's practical advice stands - treat the quality of the vendor's response as a signal. A vendor who understands what counterion exchange means and can describe their process coherently is meaningfully more trustworthy than one who cannot, even before you assess whether their documentation is complete.

The broader point I should have made more carefully from the start is that the TFA concern is real but the degree of risk at typical research quantities is not settled with the kind of precision I implied. Precautionary preference for acetate forms is reasonable. Treating TFA contamination as a confirmed acute health crisis at standard dosing ranges goes beyond what the current evidence directly supports.

SupplierSkeptic, thank you for holding the line on that. This is exactly the kind of scrutiny these discussions need.